Elizabeth E. Reed, SVP, GC & Corporate Secretary at Travere Therapeutics, Inc. (TVTX), sold 5,000 shares at $27.40 ($137K) on 2022-01-11, disclosed to the SEC on 2022-01-12.
Open-market sale of $137k TVTX by SVP, GC & Corporate Secretary. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| TVTX | SELL | 2026-04-15 | $2.1M | — | Filing → |
| TVTX | SELL | 2026-04-02 | $300K | — | Filing → |
| TVTX | SELL | 2026-03-18 | $562K | — | Filing → |